Physician profile
Richard A Driscoll
NPI 1336226174
$3,515.56
in general payments reported to CMS, 2019-2025
15 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $210 · 2021: $653 · 2022: $458 · 2023: $739 · 2024: $577 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,176.49 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $559.81 | 2022-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $530.50 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $285.74 | 2019-2023 | Axert |
| Alcon Vision LLC | $187.23 | 2019-2025 | Precision 1, Dailies Total1 |
| Biotissue Holdings INC. | $141.09 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $134.10 | 2021 | |
| Shire North American Group INC | $122.08 | 2019 | |
| Allergan, INC. | $113.24 | 2022 | |
| Abbvie INC. | $111.50 | 2023 | Durysta |
| Abb Con-Cise Optical Group LLC | $82.25 | 2019-2021 | |
| Sight Sciences, INC. | $22.37 | 2020 | |
| Sun Pharmaceutical Industries INC. | $18.20 | 2021 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $13.76 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Driscoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.